Albemarle Corporation (ALB)
Stock Price Chart
Key Info
| Market Cap | 8.98B |
| Revenue (ttm) | 3.38B |
| Net Income (ttm) | 438.29M |
| Shares Out | 106.36M |
| EPS (ttm) | 4.12 |
| PE Ratio | 20.50 |
| Forward PE | 24.27 |
| Dividend | $1.54 |
| Dividend Yield | 1.82% |
Stock Quote
| Trading Day | Aug 7, 2020 |
| Last Price | $84.44 |
| Previous Close | $83.34 |
| Change ($) | 1.10 |
| Change (%) | 1.32% |
| Day's Open | 83.00 |
| Day's Range | 82.65 - 86.42 |
| Day's Volume | 1,236,340 |
| 52-Week Range | 48.89 - 99.40 |
More Stats
| Market Cap | 8.98B |
| Enterprise Value | 11.80B |
| Earnings Date (est) | Nov 4, 2020 |
| Ex-Dividend Date | Jun 11, 2020 |
| Shares Outstanding | 106.36M |
| Float | 105.75M |
| EPS (basic) | 4.13 |
| EPS (diluted) | 4.12 |
| FCF / Share | -1.20 |
| Dividend | $1.54 |
| Dividend Yield | 1.82% |
| Earnings Yield | 4.88% |
| FCF Yield | n/a |
| Payout Ratio | 36.40% |
| Shares Short | 12.38M |
| Short Ratio | 11.03 |
| Short % of Float | 13.32% |
| Beta | 1.46 |
| PE Ratio | 20.50 |
| Forward PE | 24.27 |
| P/FCF Ratio | n/a |
| PS Ratio | 2.66 |
| PB Ratio | 2.26 |
| Revenue | 3.38B |
| Operating Income | 561.48M |
| Net Income | 438.29M |
| Free Cash Flow | -127.16M |
| Net Cash | -2.82B |
| Net Cash / Share | -26.55 |
| Gross Margin | 37.32% |
| Operating Margin | 16.64% |
| Profit Margin | 13.00% |
| FCF Margin | -3.77% |
| ROA | 4.53% |
| ROE | 12.35% |
| ROIC | 6.50% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,589 | 3,375 | 3,072 | 2,677 | 2,826 | 2,446 | 2,394 | 2,519 | 2,869 | 2,363 |
| Revenue Growth | 6.35% | 9.86% | 14.75% | -5.28% | 15.57% | 2.14% | -4.96% | -12.19% | 21.43% | - |
| Gross Profit | 1,258 | 1,217 | 1,106 | 970 | 860 | 771 | 850 | 899 | 955 | 742 |
| Operating Income | 666 | 701 | 572 | 479 | 345 | 271 | 577 | 400 | 518 | 402 |
| Net Income | 533 | 694 | 54.85 | 644 | 335 | 133 | 413 | 312 | 392 | 316 |
| Shares Outstanding | 106 | 108 | 111 | 112 | 111 | 78.70 | 83.84 | 89.19 | 90.52 | 91.39 |
| Earnings Per Share | 5.02 | 6.34 | 0.49 | 5.68 | 3.00 | 1.69 | 4.90 | 3.47 | 4.28 | 3.43 |
| EPS Growth | -20.82% | 1193.88% | -91.37% | 89.33% | 77.51% | -65.51% | 41.21% | -18.93% | 24.78% | - |
| Dividend Per Share | 1.47 | 1.34 | 1.28 | 1.22 | 1.16 | 1.10 | 0.96 | 0.80 | 0.67 | 0.56 |
| Dividend Growth | 9.7% | 4.69% | 4.92% | 5.17% | 5.45% | 14.58% | 20% | 19.4% | 19.64% | - |
| Operating Cash Flow | 719 | 546 | 304 | 736 | 361 | 493 | 433 | 489 | 487 | 331 |
| Capital Expenditures | -841 | -700 | -318 | -197 | -228 | -111 | -155 | -281 | -191 | -75.48 |
| Free Cash Flow | -122 | -154 | -13.72 | 539 | 133 | 382 | 278 | 208 | 297 | 256 |
| Cash & Equivalents | 613 | 555 | 1,137 | 2,270 | 214 | 2,490 | 477 | 478 | 469 | 530 |
| Total Debt | 3,073 | 1,705 | 1,837 | 2,369 | 3,817 | 2,934 | 1,079 | 699 | 764 | 861 |
| Net Cash / Debt | -2,460 | -1,150 | -700 | -99.51 | -3,603 | -444 | -602 | -222 | -294 | -331 |
| Assets | 9,861 | 7,582 | 7,751 | 8,161 | 9,598 | 5,223 | 3,585 | 3,437 | 3,204 | 3,068 |
| Liabilities | 5,767 | 3,823 | 3,933 | 4,219 | 6,197 | 3,734 | 1,842 | 1,505 | 1,525 | 1,592 |
| Book Value | 3,932 | 3,585 | 3,675 | 3,795 | 3,254 | 1,359 | 1,627 | 1,834 | 1,591 | 1,416 |
Company Profile
Company Details
| Full Name | Albemarle Corporation |
| Country | United States |
| Employees | 6,000 |
| CEO | Jerry Kent Masters |
Stock Information
| Ticker Symbol | ALB |
| Stock Exchange | New York Stock Exchange |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Unique Identifier | NYSE: ALB |
| IPO Date | February 17, 1994 |
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company operates in three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment offers hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. The company serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1994 and is headquartered in Charlotte, North Carolina.